Matrix metalloproteinase-7 is a urinary biomarker and pathogenic mediator of kidney fibrosis

Journal of the American Society of Nephrology

Volumn 28, Issue 2, 2017, Pages 598-611

  Zhou, Dong ^a   Tian, Yuan ^b   Sun, Ling ^b   Zhou, Lili ^b   Xiao, Liangxiang ^b   Tan, Roderick J ^a   Tian, Jianwei ^b   Fu, Haiyan ^a   Hou, Fan Fan ^b   Liu, Youhua ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; BIOLOGICAL MARKER; CALVASCULIN; COLLAGEN TYPE 1; CREATININE; CYSTATIN C; GELATINASE A; GELATINASE B; MATRILYSIN; MATRILYSIN INHIBITOR; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 17; MESSENGER RNA; NEUTROPHIL COLLAGENASE; STROMELYSIN; STROMELYSIN 2; UVOMORULIN; VIMENTIN; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CELL LYSATE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMPLEX FORMATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE TRANSLOCATION; GENETIC BACKGROUND; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE; KIDNEY TUBULE CELL; KIDNEY TUBULE EPITHELIUM; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEINURIA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URETER OBSTRUCTION; WESTERN BLOTTING; ANIMAL; FIBROSIS; KIDNEY; KIDNEY DISEASE; PATHOLOGY; PHYSIOLOGY; URINE;

ANIMALS; BETA CATENIN; BIOMARKERS; FIBROSIS; HUMANS; KIDNEY; KIDNEY DISEASES; MATRIX METALLOPROTEINASE 7; MICE; RENAL INSUFFICIENCY, CHRONIC;

EID: 85021414635     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2016030354     Document Type: Article

References (41)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
2. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, WangW, Li X, Wang H: Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet 379: 815-822, 2012
3. Liu Y: Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7: 684-696, 2011
4. Boor P, Ostendorf T, Floege J: Renal fibrosis: Novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 6: 643-656, 2010
5. Farris AB, Adams CD, Brousaides N, Della Pelle PA, Collins AB, Moradi E, Smith RN, GrimmPC, Colvin RB:Morphometric and visual evaluation of fibrosis in renal biopsies. J Am Soc Nephrol 22: 176-186, 2011
6. Farris AB, Alpers CE: What is the best way to measure renal fibrosis?: A pathologist's perspective. Kidney Int Suppl (2011) 4: 9-15, 2014
7. Wong MG, Pollock CA: Biomarkers in kidney fibrosis: Are they useful?. Kidney Int Suppl (2011) 4: 79-83, 2014
8. Genovese F, Manresa AA, Leeming DJ, Karsdal MA, Boor P: The extracellular matrix in the kidney: A source of novel non-invasive biomarkers of kidney fibrosis?. Fibrogenesis Tissue Repair 7: 4, 2014
9. Lee SB, Kanasaki K, Kalluri R: Circulating TGF-beta1 as a reliable biomarker for chronic kidney disease progression in the African-American population. Kidney Int 76: 10-12, 2009
10. He W, Tan RJ, Li Y, Wang D, Nie J, Hou FF, Liu Y: Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/b-catenin activity in CKD. J Am Soc Nephrol 23: 294-304, 2012
11. Tan RJ, Liu Y: Matrix metalloproteinases in kidney homeostasis and diseases. Am J Physiol Renal Physiol 302: F1351-F1361, 2012
12. Yong VW: Metalloproteinases: Mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 6: 931-944, 2005
13. McGuire JK, Li Q, Parks WC: Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol 162: 1831-1843, 2003
14. Vargo-Gogola T, Crawford HC, Fingleton B, Matrisian LM: Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys 408: 155-161, 2002
15. Mitsiades N, Yu WH, Poulaki V, Tsokos M, Stamenkovic I: Matrix metalloproteinase-7-mediated cleavage of Fas ligandprotects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res 61: 577-581, 2001
16. Haro H, Crawford HC, Fingleton B, Shinomiya K, Spengler DM, Matrisian LM: Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J Clin Invest 105: 143-150, 2000
17. Rosas IO, Richards TJ, Konishi K, Zhang Y, Gibson K, Lokshin AE, Lindell KO, Cisneros J, Macdonald SD, Pardo A, Sciurba F, Dauber J, SelmanM, Gochuico BR, Kaminski N: MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathicpulmonary fibrosis. PLoSMed 5: E93, 2008
18. Surendran K, Simon TC, Liapis H, McGuire JK: Matrilysin (MMP-7) expression in renal tubular damage: Association withWnt4. Kidney Int 65: 2212-2222, 2004
19. Zhou D, Tan RJ, Fu H, Liu Y: Wnt/b-catenin signaling in kidney injury and repair: A double-edged sword. Lab Invest 96: 156-167, 2016
20. Tan RJ, Zhou D, Zhou L, Liu Y: Wnt/b-catenin signaling and kidney fibrosis. Kidney Int Suppl (2011) 4: 84-90, 2014
21. Zhou L, Liu Y: Wnt/b-catenin signalling and podocyte dysfunction in proteinuric kidney disease. Nat Rev Nephrol 11: 535-545, 2015
22. Matsuyama M, Nomori A, Nakakuni K, Shimono A, Fukushima M: Secreted Frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy. J Biol Chem 289: 31526-31533, 2014
23. DiRocco DP, Kobayashi A, Taketo MM, McMahon AP, Humphreys BD: Wnt4/b-catenin signaling in medullary kidney myofibroblasts. J Am Soc Nephrol 24: 1399-1412, 2013
24. HeW, Dai C, Li Y, Zeng G, Monga SP, Liu Y:Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20: 765-776, 2009
25. Hao S, HeW, Li Y, DingH, Hou Y, Nie J, Hou FF, Kahn M, Liu Y: Targeted inhibition of b-catenin/CBP signaling ameliorates renal interstitial fibrosis. J AmSoc Nephrol 22: 1642-1653, 2011
26. Liu Y: Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15: 1-12, 2004
27. Zeisberg M, Neilson EG: Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437, 2009
28. Emami KH, Nguyen C, Ma H, Kim DH, Jeong KW, Eguchi M, Moon RT, Teo JL, KimHY, Moon SH, Ha JR, KahnM: A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. ProcNatl Acad Sci U S A 101: 12682-12687, 2004
29. Henderson WR Jr., Chi EY, Ye X, Nguyen C, Tien YT, Zhou B, Borok Z, Knight DA, Kahn M: Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci U S A 107: 14309-14314, 2010
30. Zhou L, Li Y, Zhou D, Tan RJ, Liu Y: Loss of Klotho contributes to kidney injury by derepression of Wnt/b-catenin signaling. J Am Soc Nephrol 24: 771-785, 2013
31. Wang X, Zhou Y, Tan R, XiongM, HeW, Fang L, Wen P, Jiang L, Yang J: Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 299: F973-F982, 2010
32. Tan TK, Zheng G, Hsu TT, Wang Y, Lee VW, Tian X, Wang Y, Cao Q, Wang Y, Harris DC: Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells. Am J Pathol 176: 1256-1270, 2010
33. Lovisa S, LeBleu VS, Tampe B, Sugimoto H, Vadnagara K, Carstens JL, Wu CC, Hagos Y, Burckhardt BC, Pentcheva-Hoang T, Nischal H, Allison JP, Zeisberg M, Kalluri R: Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med 21: 998-1009, 2015
34. Grande MT, Sánchez-Laorden B, López-Blau C, De Frutos CA, Boutet A, Arévalo M, Rowe RG, Weiss SJ, López-Novoa JM, NietoMA: Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med 21: 989-997, 2015
35. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350, 2002
36. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, Duffield JS: Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176: 85-97, 2010
37. Quaggin SE, Kapus A: Scar wars: Mapping the fate of epithelialmesenchymal-myofibroblast transition. Kidney Int 80: 41-50, 2011
38. Zhou D, Liu Y: Renal fibrosis in 2015: Understanding the mechanisms of kidney fibrosis. Nat Rev Nephrol 12: 68-70, 2016
39. He W, Tan R, Dai C, Li Y, Wang D, Hao S, Kahn M, Liu Y: Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling. J Biol Chem285: 24665-24675, 2010
40. Zhou L, Li Y, Hao S, Zhou D, Tan RJ, Nie J, Hou FF, Kahn M, Liu Y: Multiple genes of the renin-angiotensin system are novel targets of Wnt/b-catenin signaling. J Am Soc Nephrol 26: 107-120, 2015
41. Zhou D, Li Y, Zhou L, Tan RJ, Xiao L, Liang M, Hou FF, Liu Y: Sonic hedgehog is a novel tubule-derived growth factor for interstitial fibroblasts after kidney injury. J Am Soc Nephrol 25: 2187-2200, 2014